세계의 심장 안전 서비스 시장 - 규모, 점유율, 동향분석 보고서 : 서비스별, 유형별, 최종용도별, 지역별, 부문 예측(2025-2030년)

Cardiac Safety Services Market Size, Share & Trends Analysis Report By Service (ECG/Holter Monitors, Blood Pressure Monitors), By Type (Integrated, Standalone), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,163,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,536,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,280,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

심장 안전 서비스 시장 성장과 동향

Grand View Research, Inc.의 조사 보고서에 따르면 세계의 심장 안전 서비스 시장 규모는 2030년까지 19억 2,430만 달러에 달할 것으로 예측되고, 2025-2030년 동안 CAGR은 12.1%를 나타낼 것으로 예측됩니다. 이 성장의 원동력은 심혈관 질환(CVDs)의 우려하는 만연과 의료 기술의 현저한 진보입니다. 미국 CDC에 따르면 미국에서는 33초에 한 명이 심혈관계 질환으로 사망하고 있으며 효과적인 심장 모니터링과 개입의 필요성을 강조하고 있습니다. 2022년에는 심장병이 702,880명의 사망을 일으켰으며, 이는 사망자 중 5명 중 1명에 해당하며 심장 안전 서비스의 엄청난 시장 잠재력을 돋보이게 합니다.

게다가 미국에서는 매년 약 80만 5,000명이 심장 발작을 경험하고 있으며, 그 중 60만 5,000명이 최초의 심장 발작, 20만명이 이전에 심장 발작을 일으켰던 적이 있는 사람입니다. 임상검사의 확대, 특히 심혈관계 질환에 초점을 맞춘 임상검사와 심혈관계에 영향을 미칠 수 있는 치료의 임상검사가 심장안전성 서비스에 대한 수요를 끌어올리고 있습니다. 제약회사나 바이오의약품회사가 심혈관에 관한 신약 및 신장치의 개발에 투자함에 따라, 이들 제품이 심장 건강에 악영향을 미치지 않는 것을 확인하기 위한 전문적인 심장 안전성 평가의 필요성이 높아지고 있습니다. 이러한 임상검사 증가와 최신의 임상검사의 복잡성이 결합되어 의약품 개발과 규제 준수를 지원하는 견고하고 신뢰할 수 있는 심장안전성 서비스가 필요합니다.

제약회사, 의료기기 제조업체, 학술기관은 심장안전성 서비스 시장의 혁신과 성장을 가속하기 위해 지속적으로 연구개발에 투자하고 있습니다. R&D는 새로운 치료법과 기술 개발을 지원하기 위해 첨단 심장 안전 모니터링이 필요합니다. 이러한 투자는 새로운 심장 안전 솔루션의 개발을 촉진하고 기존 서비스의 지속적인 개선을 지원합니다.

심장 안전 서비스 시장 보고서 하이라이트

• 서비스별로는 ECG/홀터 모니터 부문이 2024년 매출 점유율 41.0%로 시장을 선도하고 있습니다. 심전도(ECG)와 홀터 모니터는 지속적인 심장 모니터링을 위한 중요한 도구로 부정맥, 허혈성 에피소드 및 기타 심혈관 질환의 실시간 검출을 가능하게 합니다.
• 유형별로 통합형은 2024년 63.0%의 최대 판매 점유율로 시장을 선도했습니다. 이러한 이점은 주로 환자의 정확성, 효율성 및 편의성을 향상시키는 종합적인 다기능 심장 모니터링 솔루션에 대한 수요 증가로 인한 것입니다.
• 최종 용도별로는 의약품 및 바이오의약품 부문이 2024년에 44.0%의 최대 수익 점유율로 시장을 선도했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 심장 안전 서비스 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 심장 안전 서비스 시장 분석 도구
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 심장 안전 서비스 시장 : 서비스별, 추정·동향 분석

• 세계의 심장 안전 서비스 시장 : 서비스 대시보드
• 세계의 심장 안전 서비스 시장 : 서비스 변동 분석
• 서비스별, 수익별
• ECG/홀터 모니터
• 혈압 모니터
• 심장혈관 영상 진단
• 기타

제5장 심장 안전 서비스 시장 : 유형별, 추정·동향 분석

• 세계의 심장 안전 서비스 시장 : 유형 대시보드
• 세계의 심장 안전 서비스 시장 : 유형 변동 분석
• 유형별, 수익
• 통합형
• 독립형

제6장 심장 안전 서비스 시장 : 최종용도별, 추정·동향 분석

• 세계의 심장 안전 서비스 시장 : 최종 용도 대시보드
• 세계의 심장 안전 서비스 시장 : 최종용도 변동 분석
• 최종 용도별, 수익
• 의약품 및 바이오의약품
• CRO
• 기타

제7장 심장 안전 서비스 시장 : 서비스, 유형, 최종용도에 따른 지역별, 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 기업/경쟁의 분류
• 벤더 상황
  • 주요 리셀러와 채널 파트너 목록
  • 주요 기업의 시장 점유율 분석, 2023년
  • Medpace
  • IQVIA
  • PPD Inc.
  • Charles River Laboratories
  • Wuxi AppTec
  • Eurofins Scientific
  • Celerion
  • Nova Research Laboratories
  • Laboratory Corporation of America Holdings
  • Koninklije Philips NV
  • ICON Plc.
  • SGS SA
  • Clario
  • Certara

JHS

영문 목차

영문목차

Cardiac Safety Services Market Growth & Trends:

The global cardiac safety services market size is anticipated to reach USD 1,924.3 million by 2030 and is projected to grow at a CAGR of 12.1% from 2025 to 2030, according to a report by Grand View Research, Inc. This growth is driven by the alarming prevalence of cardiovascular diseases (CVDs) and significant advancements in medical technology. As per the CDC, in U.S., one person dies due to any cardiovascular disease every 33 seconds, underscoring the critical need for effective cardiac monitoring and intervention. In 2022, heart disease caused 702,880 deaths, representing one in every five deaths and highlighting the vast market potential for cardiac safety services.

Moreover, approximately 805,000 people in the U.S. experience a heart attack each year, with 605,000 being first-time incidents and 200,000 involving individuals who have previously suffered a heart attack. Expanding clinical trials, particularly those focused on cardiovascular diseases or involving therapies with potential cardiovascular impacts, drives the demand for cardiac safety services. As pharmaceutical and biopharmaceutical companies invest in developing new cardiovascular drugs and devices, there is an increased need for specialized cardiac safety assessments to ensure that these products do not adversely affect heart health. This growth in clinical trials, combined with the complexity of modern trials, necessitates robust and reliable cardiac safety services to support drug development and regulatory compliance.

Pharmaceutical companies, medical device manufacturers, and academic institutions continually invest in R&D to drive innovation and growth in the cardiac safety services market. Research initiatives often require sophisticated cardiac safety monitoring to support the development of new therapies and technologies. This investment fosters the development of new cardiac safety solutions and supports continuously improving existing services.

Cardiac Safety Services Market Report Highlights:

• Based on service, the ECG/Holter monitors segment led the market with the largest revenue share of 41.0% in 2024. Electrocardiogram (ECG) and Holter monitors are crucial tools for continuous cardiac monitoring, enabling real-time detection of arrhythmias, ischemic episodes, and other cardiovascular conditions
• Based on type, the integrated segment led the market with the largest revenue share of 63.0% in 2024. This prominence is primarily driven by the increasing demand for comprehensive, multi-functional cardiac monitoring solutions that offer enhanced accuracy, efficiency, and patient convenience
• Based on end use, the pharma & biopharma segment led the market with the largest revenue share of 44.0% in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Service Outlook
  • 2.2.2. Type
  • 2.2.3. End Use
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Safety Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cardiovascular diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Government Initiatives aimed at improving healthcare outcomes
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High costs
    • 3.2.2.2. Regulatory challenge
• 3.3. Cardiac Safety Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Cardiac Safety Services Market: Service Estimates & Trend Analysis

• 4.1. Global Cardiac Safety Services Market: Service Dashboard
• 4.2. Global Cardiac Safety Services Market: Service Movement Analysis
• 4.3. Global Cardiac Safety Services Market by Service, Revenue
• 4.4. ECG/ Holter Monitors
  • 4.4.1. ECG/ Holter Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.1. ECG Patch
      • 4.4.1.1.1. ECG Patch market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Holter Monitors
    • 4.4.1.3. Holter Monitors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Blood Pressure Monitors
  • 4.5.1. Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.1. Aneroid Blood Pressure Monitors
      • 4.5.1.1.1. Aneroid Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.2. Digital Blood Pressure Monitors
      • 4.5.1.2.1. Digital Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.1.3. Ambulatory Blood Pressure Monitors
      • 4.5.1.3.1. Ambulatory Blood Pressure Monitors market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Cardiovascular Imaging
  • 4.6.1. Cardiovascular Imaging market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.1. CT
      • 4.6.1.1.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.2. MRI
      • 4.6.1.2.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.3. Ultrasound
      • 4.6.1.3.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.1.4. Nuclear Medicine
      • 4.6.1.4.1. Nuclear Medicine market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cardiac Safety Services Market: Type Estimates & Trend Analysis

• 5.1. Global Cardiac Safety Services Market: Type Dashboard
• 5.2. Global Cardiac Safety Services Market: Type Movement Analysis
• 5.3. Global Cardiac Safety Services Market Estimates and Forecasts, By Type, Revenue (USD Million)
• 5.4. Integrated
  • 5.4.1. Integrated market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Standalone
  • 5.5.1. Standalone market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cardiac Safety Services Market: End Use Estimates & Trend Analysis

• 6.1. Global Cardiac Safety Services Market: End Use Dashboard
• 6.2. Global Cardiac Safety Services Market: End Use Movement Analysis
• 6.3. Global Cardiac Safety Services Market Estimates and Forecasts, By End Use, Revenue (USD Million)
• 6.4. Pharma & Biopharma Companies
  • 6.4.1. Pharma & Biopharma Companies market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. CROs
  • 6.5.1. CROs market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Other
  • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cardiac Safety Services Market: Regional Estimates & Trend Analysis by Treatment, Type, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key company market share analysis, 2023
  • 8.2.3. Medpace
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Service benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. IQVIA
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Service benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. PPD Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Service benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Charles River Laboratories
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Service benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Wuxi AppTec
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Service benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Eurofins Scientific
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Service benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Celerion
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Service benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Nova Research Laboratories
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Service benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Laboratory Corporation of America Holdings
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Service benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Koninklije Philips N.V.
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Service benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. ICON Plc.
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Service benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. SGS S.A.
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Service benchmarking
    • 8.2.14.4. Strategic initiatives
  • 8.2.15. Clario
    • 8.2.15.1. Company overview
    • 8.2.15.2. Financial performance
    • 8.2.15.3. Service benchmarking
    • 8.2.15.4. Strategic initiatives
  • 8.2.16. Certara
    • 8.2.16.1. Company overview
    • 8.2.16.2. Financial performance
    • 8.2.16.3. Service benchmarking
    • 8.2.16.4. Strategic initiatives

관련자료